BJPsych Open, published by Cambridge University Press, is a leading open access journal dedicated to the field of psychiatry and mental health. Since its inception in 2015, the journal has provided a platform for disseminating cutting-edge research and evidence-based practices, making significant contributions to the academic community. With an impressive impact factor and currently ranking in the top Q1 quartile of its field, BJPsych Open is recognized for its rigor and relevance, ranking 138 out of 567 journals in psychiatry and mental health according to Scopus, placing it in the 75th percentile. The journal's commitment to open access enhances visibility and accessibility, ensuring that vital research is available to a global audience. Researchers, professionals, and students alike will find valuable insights into contemporary mental health challenges and innovative treatment approaches, making BJPsych Open an essential resource for advancing mental health scholarship.

Asian Journal of Psychiatry, published by ELSEVIER, is a leading international forum dedicated to advancing knowledge and understanding in the fields of psychiatry, psychology, and mental health. With an impressive impact factor that places it in the prestigious Q1 category for both Psychiatry and Mental Health as well as for General Psychology, it ranks among the top journals in its field, demonstrating a significant contribution to academic and clinical research. The journal seeks to disseminate high-quality research articles, review papers, and clinical studies that inform best practices and impact policy in mental health treatment across Asia and beyond. With a focus on innovative methodologies and culturally relevant frameworks, the Asian Journal of Psychiatry is an essential resource for researchers, clinicians, and students striving to enhance mental health services in a diverse and evolving landscape. The journal is accessible through standard academic libraries and does not currently offer Open Access options, ensuring that its content remains a respected part of scholarly discourse.

Lancet Psychiatry is a prestigious peer-reviewed journal published by Elsevier, focusing on the vital fields of psychiatry and mental health. With an impressive impact factor and a top-tier ranking of Q1 in both Biological Psychiatry and Psychiatry & Mental Health, this journal is recognized for its significant contribution to the understanding and treatment of mental health disorders. Established in 2014 and set to continue its influence until at least 2024, Lancet Psychiatry serves as an essential resource for researchers, professionals, and students engaged in the complex interplay of mental health and biological sciences. Based in the United Kingdom, it is conveniently accessible and offers a platform for cutting-edge research that shapes clinical practices and informs policy decisions in mental health care. With its formidable positioning within the Scopus rankings—holding the #2 spot in Psychiatry and Mental Health and #1 in Biological Psychiatry—this journal remains at the forefront of scientific discourse, fostering innovation and advancing knowledge in the cerebral realms of psychiatry.

Journal of Experimental Psychopathology, published by SAGE Publications Ltd, stands as a pivotal platform for advancing the understanding of psychological disorders and their underlying mechanisms. Established in 2015, this open access journal encourages a broad dissemination of research findings, adhering to its mission to foster innovation in the fields of Clinical Psychology and Psychiatry and Mental Health. With an established impact recognized in its Q3 quartile rankings for both fields as of 2023, the journal aims to bridge the gap between experimental research and clinical application. Researchers, professionals, and students are invited to engage with cutting-edge studies, all while benefiting from the journal's commitment to open access publishing since 2018, ensuring that knowledge is easily accessible to all. The journal’s office is strategically located in London, UK, serving a global academic community keen on exploring the complexities of psychopathology.

PSYCHIATRIE DE L ENFANT is a distinguished academic journal published by PRESSES UNIV FRANCE, focusing on the significant realm of child psychiatry and developmental psychology. With its ISSN 0079-726X and E-ISSN 2102-5320, this journal provides a platform for researchers, practitioners, and educators to explore various topics surrounding mental health in children. Although the coverage in Scopus has been discontinued since 2018, with ranks highlighting its placement in the Developmental and Educational Psychology and Psychiatry and Mental Health categories, the journal's contributions remain pivotal for professionals aiming to advance their understanding of child mental health. Though it does not currently offer open access, the journal invites rigorous studies, clinical insights, and theoretical discussions that are crucial for the evolution of child psychiatry. As such, PSYCHIATRIE DE L ENFANT plays an essential role in shaping future research and practices in the field.

Canadian Journal of Psychiatry-Revue Canadienne de Psychiatrie, published by SAGE Publications Inc, has established itself as a leading voice in the field of psychiatry and mental health since its inception in 1979. With an impact factor that places it in the top quartile (Q1) of its category as of 2023, this journal ranks impressively at #112 out of 567 in the Scopus database, highlighting its significance and influence in the academic community. The journal provides a vital platform for disseminating cutting-edge research, innovative methodologies, and critical reviews, making it an essential resource for researchers, practitioners, and students alike. Although it currently does not offer open access, the journal's commitment to advancing the understanding of psychiatric disorders and mental health issues is unwavering. Situated in Canada, it serves both a national and international audience, fostering collaboration and knowledge sharing across disciplines. As the journal continues to evolve through 2024, it remains dedicated to enhancing the quality of mental health care and promoting the importance of psychiatric research.

Welcome to the Spanish Journal of Psychiatry and Mental Health, a leading platform for innovative research and discourse in the fields of psychiatry and mental health. Published by ELSEVIER ESPANA SLU, this peer-reviewed journal serves as a critical resource for clinicians, researchers, and students dedicated to advancing understanding and treatment of mental health disorders. With a commendable ranking of #54 out of 567 in the Psychiatry and Mental Health category according to Scopus, it proudly positions itself in the 90th percentile, reinforcing its significance within the academic community. As an open-access journal, it aims to disseminate high-quality research to a global audience, promoting collaboration and knowledge sharing among mental health professionals. The journal's dynamic publication schedule, covering Converged Years from 2023 to 2024, ensures that it remains at the forefront of mental health scholarship. We invite you to explore the latest findings, engage with thought-provoking articles, and contribute to the ongoing dialogue in this vital discipline.

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

Welcome to EVOLUTION PSYCHIATRIQUE, a prominent journal in the field of Psychiatry and Mental Health published by ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER. With a rich publication history dating back to 1948, this journal serves as a critical platform for the dissemination of cutting-edge research and insights within the realm of mental health. As of 2023, it has attained a commendable position in the Q2 quartile for Arts and Humanities and Q4 for Psychiatry and Mental Health, reflecting its diverse contributions to the scholarly community. The journal’s unique scope encompasses both theoretical and empirical studies that inform and invigorate the dialogue surrounding psychiatric evolution. Despite its current non-open access status, EVOLUTION PSYCHIATRIQUE remains a pivotal resource for researchers, clinicians, and students alike, offering valuable perspectives that illuminate the complexities of mental health across different genres of study and practice. Through rigorous peer review and a commitment to scientific integrity, this journal continues to foster advancements and discussions that are essential for the progress of psychiatry in contemporary society.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.